The high-dose Biotin pill that MedDay was testing has failed a second Phase III clinical trial. The company says the medication failed to meet both primary and secondary endpoints. https://bit.ly/2Q431Ao
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.